Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib



Status:Active, not recruiting
Conditions:Liver Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:3/3/2019
Start Date:September 26, 2013
End Date:October 2019

Use our guide to learn which trials are right for you!

A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib

The purpose of this study is to evaluate the effect of Cabozantinib (XL184) compared with
placebo on overall survival in subjects with advanced hepatocellular carcinoma who have
received prior sorafenib.


Select Inclusion Criteria:

1. Histological or cytological diagnosis of HCC.

2. The subject has disease that is not amenable to a curative treatment approach.

3. Received prior sorafenib.

4. Progression following at least 1 prior systemic treatment for HCC.

5. Recovery to from toxicities related to any prior treatments.

6. ECOG performance status of 0 or 1.

7. Adequate hematologic and renal function, based upon meeting protocol defined
laboratory criteria within 7 days before randomization.

8. Child-Pugh Score of A.

9. Antiviral therapy per local standard of care if active hepatitis B (HBV) infection.

10. Sexually active fertile subjects(male and female)must agree to use medically accepted
methods of contraception during the course of the study and for 4 months after the
last dose of study treatment.

11. Female subjects of childbearing potential must not be pregnant at screening.

Select Exclusion Criteria:

1. Fibrolamellar carcinoma or mixed hepatocellular cholangiocarcinoma.

2. Receipt of more than 2 prior systemic therapies for advanced HCC.

3. Any type of anticancer agent (including investigational) within 2 weeks before
randomization.

4. Radiation therapy within 4 weeks (2 weeks for radiation for bone metastases) or
radionuclide treatment within 6 weeks of randomization.

5. Prior cabozantinib treatment.

6. Known brain metastases or cranial epidural disease unless adequately treated with
radiotherapy and/or surgery and stable for at least 3 months before randomization.

7. Concomitant anticoagulation, at therapeutic doses, with anticoagulants.

8. Serious illness other than cancer that would preclude safe participation in the study.

9. Subjects with untreated or incompletely treated varices with bleeding or high risk for
bleeding.

10. Moderate or severe ascites.

11. Pregnant or lactating females.

12. Diagnosis of another malignancy within 2 years before randomization, except for
superficial skin cancers, or localized, low-grade tumors.
We found this trial at
24
sites
?
mi
from
Corona, CA
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Burlington, MA
Click here to add this to my saved trials
?
mi
from
Camperdown,
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
?
mi
from
East Orange, NJ
Click here to add this to my saved trials
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
?
mi
from
Honolulu, HI
Click here to add this to my saved trials
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Rochester, MN
Click here to add this to my saved trials
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
?
mi
from
San Diego, CA
Click here to add this to my saved trials
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
?
mi
from
Seattle, WA
Click here to add this to my saved trials
?
mi
from
Seattle, WA
Click here to add this to my saved trials
?
mi
from
Spokane, WA
Click here to add this to my saved trials
?
mi
from
Valhalla, NY
Click here to add this to my saved trials